Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Box Inc (BOX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs Box Inc — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $220.27 (market cap $29.60B), while Box Inc trades at $32.49 (market cap $4.55B). The key difference: Alnylam Pharmaceuticals, Inc. is far larger — about 6.5× Box Inc's market cap, and Box Inc is trading nearer its 52-week high, Alnylam Pharmaceuticals, Inc. nearer its low. Which is the better fit depends on your goals.
| ALNY | BOX | |
|---|---|---|
Market Cap | $29.60B | $4.55B |
Sector | Health | Technology |
52-Week High | $491.22 | $33.60 |
52-Week Low | $205.48 | $21.37 |
Enterprise Value | $27.56B | $5.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
BOX trades at $33.6, up 1.08% today, with a bullish technical signal and strong analyst consensus. Revenue grew to $1.09B in 2025, with net income reaching $244.62M and a high gross margin of 79.56%. Recent news highlights Box's AI-ready content platform adoption, such as the Quintas Energy partnership announced on July 30, 2026.
The outlook is positive with a $37 consensus price target, but risks include a high P/E of 51.3 and competitive pressures. Earnings beat expectations in two of the last three quarters, supporting growth momentum, though valuation remains elevated relative to peers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About Box Inc
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →
